We are Sorry, This Page doesn't Exist

The $24 million mediated settlement stems from a string of patient deaths that nearly derailed Seattle's star biotech startup two years ago......»»

Former Juno Therapeutics Inc. executives Hans Bishop and Steve Harr have co-founded a new biotech, Sana Biotechnology Inc., less than a year after leading Juno through a $9 billion acquisition by Celgene Corp......»»

Renowned guru slims position in biotech company that focuses on kidney diseaseCheck out Seth Klarman Stock Picks » Download GuruFolio Report of Seth Klarman (Updated on 04/13/2020)Related Stocks: AKBA, TBPH, TBIO, ATRA, GOSS, PRTK,.....»»

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

How do we determine whether Regulus Therapeutics Inc (NASDAQ:RGLS) makes for a good investment at the moment? We analyze the sentiment of a se.....»»

Juno Therapeutics, which sold for more than $10 billion to Celgene in 2018, was the last company that was acquired in a big way......»»

LA JOLLA, Calif., March 18, 2019 /PRNewswire/ -- Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company focused on the discovery and devel.....»»

Guru adds biotech company to health care holdingsCheck out Steven Cohen Stock Picks » Download GuruFolio Report of Steven Cohen (Updated on 03/13/2019)Related Stocks: APVO, BAX, JNJ, INGN, LOXO, IQV,.....»»

Regulus Therapeutics" (RGLS) CEO Joseph Hagan on Q1 2018 Results - Earnings Call Transcript.....»»

Peter Kolchinsky is one of the best biotech investors and many of his stock picks generate strong returns. We calculate a fund’s r.....»»

(Reuters) - When U.S. biotech startup Sorrento Therapeutics named ex-Lehman Brothers executive Jiong Shao as its new finance chief about two months ago, it was widely seen as a move driven by his background in raising capital for Alibaba and Tencent......»»

The acquisition of Kite Pharmaceuticals by Gilead and Juno Therapeutics by Celgene may lead to more acquisitions of CAR-T gene therapy companiesRelated Stocks: GILD, NVS, CELG, MBIO, CYAD, CLLS, PFE, BLCM,.....»»

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

An Ohio State University spinoff developing a treatment for a deadly mitochondrial disease launched Tuesday in Boston with a $59 million round of venture capital investment. Entrada Therapeutics is using science developed by Ohio State University.....»»

Massachusetts biotech startups are not only reaching new heights in the scientific field, but in the pots of money they raise. Late last month, Cambridge startup Dewpoint Therapeutics emerged from incubation at Boston venture capital firm Polaris Partn.....»»

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Vera's disappointing offering follows several others that have been postponed or also missed their price targets......»»

Vera's disappointing offering follows several others that have been postponed or also missed their price targets......»»

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»